BE408242A - - Google Patents
Info
- Publication number
- BE408242A BE408242A BE408242DA BE408242A BE 408242 A BE408242 A BE 408242A BE 408242D A BE408242D A BE 408242DA BE 408242 A BE408242 A BE 408242A
- Authority
- BE
- Belgium
- Prior art keywords
- serum
- specific
- albumin
- pepsin
- hydrochloric acid
- Prior art date
Links
- 210000002966 serum Anatomy 0.000 claims description 39
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 27
- 108010088751 Albumins Proteins 0.000 claims description 23
- 102000009027 Albumins Human genes 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 20
- 229940111202 pepsin Drugs 0.000 claims description 15
- 102000057297 Pepsin A Human genes 0.000 claims description 14
- 108090000284 Pepsin A Proteins 0.000 claims description 14
- 229960005486 vaccine Drugs 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 210000000056 organ Anatomy 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 239000005862 Whey Substances 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 108010046377 Whey Proteins Proteins 0.000 claims description 4
- 201000008827 tuberculosis Diseases 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 2
- 230000035876 healing Effects 0.000 claims description 2
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 230000029087 digestion Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000009931 harmful effect Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 241000283086 Equidae Species 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000283707 Capra Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009566 cancer vaccine Methods 0.000 description 1
- 229940022399 cancer vaccine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003355 serines Chemical class 0.000 description 1
- 206010040400 serum sickness Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE408242A true BE408242A (enExample) |
Family
ID=72856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE408242D BE408242A (enExample) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE408242A (enExample) |
-
0
- BE BE408242D patent/BE408242A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Khory et al. | Materica Medica of India and Their Therapeutics | |
| JP2003535020A (ja) | 治療用の抗真菌性爪用調製物 | |
| FR2770133A1 (fr) | Phytomedicament pour le traitement et la maitrise de l'anemie a hematies falciformes et procedes de preparation de celui-ci | |
| EP0117962A1 (fr) | Procédé de préparation de graisses peroxydées par transformation biologique à faible énergie, produits obtenus par ce procédé, mélanges de ces produits avec des additifs et nouveaux médicaments constitués de ces produits | |
| BE408242A (enExample) | ||
| FR3055215A1 (fr) | Composition comprenant des extraits de pollen et /ou de pistils | |
| CA2251009A1 (fr) | Medicament optimisant la viscosite des mucus et stimulant le fonctionnement de l'intestin | |
| FR2843883A1 (fr) | Extraits de sangsues pour psoriasis | |
| FR2686251A1 (fr) | Composition pour la cicatrisation d'une plaie. | |
| RU2162352C1 (ru) | Способ лечения псориаза | |
| BE528932A (enExample) | ||
| RU2781332C1 (ru) | Способ эндоскопического лечения химических ожогов пищевода | |
| US20030077257A1 (en) | Method for preventing and curing diseases of an immune system and a remedy for carrying out said method | |
| EP1633392A2 (fr) | Vecteur pour administration par voie orale | |
| CN112353786A (zh) | 一种亚精胺及其复合物在制备肠道免疫功能增强剂中的应用 | |
| FR2710266A1 (fr) | Nouvelles compositions en cosmétologie et dermatologie proposées dans le traitement des verrues. | |
| Roslyak | Practical experience in the treatment and prevention of viral diseases, including coronavirus in 2020-2023 | |
| FR2500305A1 (fr) | Procede de preparation d'un extrait de sperme, extrait obtenu selon ce procede et son utilisation notamment en therapeutique et en cosmetique | |
| Vasey | Natural Remedies for Inflammation | |
| FR2693208A1 (fr) | Procédé d'obtention d'une composition enzymatique d'origine végétale ainsi que composition obtenue par la mise en Óoeuvre de ce procédé. | |
| CN1621045A (zh) | 一种含蜂胶的外用搽剂 | |
| CHIBANE et al. | Contribution of noninvasive ventilation in the treatment of COPD decompensation | |
| CN120478361A (zh) | N-[3-氯-4-({[2-(甲氨基)-6-(2-吡啶基)-4-嘧啶基]氨基}甲基)苯基]在治疗慢性萎缩性胃炎中的应用 | |
| CN118141112A (zh) | 一种缓解肠道氧化应激损伤的组合物及其应用 | |
| Druitt | The Surgeon's Vade Mecum: a Hand-book of the Principles and Practice of Surgery... with... Wood Engravings |